Drug dosing for cancer therapy: A stochastic model predictive control perspective.

Area of Science:

• Control Theory
• Computational Biology
• Oncology

Background:

• Stochastic Model Predictive Control (SMPC) is a robust decision-making framework for systems with inherent uncertainties.
• Cancer therapy requires precise control strategies to manage tumor dynamics and minimize treatment toxicity.

Purpose of the Study:

• To develop and evaluate a non-linear Stochastic Model Predictive Control (SMPC) formulation tailored for personalized cancer treatment.
• To address the stochastic nature of tumor growth and treatment-induced side effects within a control framework.

Main Methods:

• A non-linear SMPC algorithm was formulated to model cancer therapy dynamics.
• The model incorporated stochastic tumor growth, non-linear system dynamics, and potential treatment side effects.
• Simulations were conducted over a one-year period to assess control performance.

Main Results:

• The proposed non-linear SMPC strategy demonstrated significant effectiveness in controlling drug dosage.
• The method successfully navigated uncertainties associated with tumor growth and treatment responses.
• Simulations indicated a potential for improved therapeutic outcomes through adaptive dosing.

Conclusions:

• Non-linear SMPC offers a promising approach for optimizing cancer therapy by managing complex biological uncertainties.
• This control strategy can lead to more personalized and effective cancer treatment regimens.
• Further research should explore clinical implementation and validation of the proposed SMPC framework.